Bacitracin Zinc And Polymyxin B Sulfate Ophthalmic Ointment, Usp (

Bacitracin Zinc And Polymyxin B Sulfate Ophthalmic Ointment, Usp (
SPL v6
SPL
SPL Set ID a73654f4-949d-3da4-e053-2995a90a1fc3
Route
OPHTHALMIC
Published
Effective Date 2023-06-06
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Bacitracin (500 [USP'U]) Polymyxin B (10000 [USP'U])
Inactive Ingredients
Mineral Oil Petrolatum

Identifiers & Packaging

Marketing Status
ANDA Active Since 2008-04-25

Description

Rx only

Dosage and Administration

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection. FOR OPHTHALMIC USE ONLY

Contraindications

This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Adverse Reactions

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

How Supplied

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP is available in tubes with an ophthalmic tip applicator in the following size: tube of 3.5g -NDC 68071-5267-3


Medication Information

Dosage and Administration

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection.

FOR OPHTHALMIC USE ONLY

Contraindications

This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Adverse Reactions

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

How Supplied

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP is available in tubes with an ophthalmic tip applicator in the following size:

tube of 3.5g -NDC 68071-5267-3

Description

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP is a sterile antimicrobial ointment formulated for ophthalmic use.

Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units/mg. The structural formula for bacitracin A is:

Polymyxin B sulfate is the sulfate salt of polymyxin B 1 and B 2, which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units/mg, calculated on an anhydrous basis. The structural formulae are:

Each gram contains: Actives: Bacitracin Zinc equal to 500 bacitracin units and Polymyxin B Sulfate equal to 10,000 polymyxin B units; Inactives: Mineral Oil and White Petrolatum.

Section 42229-5

Rx only

Storage

Store between 15° to 25°C (59° to 77°F). KEEP TIGHTLY CLOSED

Keep out of reach of children.

Distributed by:

Bausch + Lomb, a division of Bausch Health US, LLC

Bridgewater, NJ 08807 USA

Manufactured by:

Bausch & Lomb Incorporated

Tampa, FL 33637 USA

© 2020 Bausch & Lomb Incorporated or its affiliates

Revised: February 2020

9130703 (Folded)

9130603 (Flat)

Warnings

Ophthalmic ointments may retard corneal healing.

Precautions

As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. Appropriate measures should be taken if this occurs.

Clinical Pharmacology

Polymyxin B sulfate attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and Haemophilus influenzae species.

Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.

Indlcatlons and Usage

For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.

Principal Display Panel


Structured Label Content

Section 42229-5 (42229-5)

Rx only

Storage

Store between 15° to 25°C (59° to 77°F). KEEP TIGHTLY CLOSED

Keep out of reach of children.

Distributed by:

Bausch + Lomb, a division of Bausch Health US, LLC

Bridgewater, NJ 08807 USA

Manufactured by:

Bausch & Lomb Incorporated

Tampa, FL 33637 USA

© 2020 Bausch & Lomb Incorporated or its affiliates

Revised: February 2020

9130703 (Folded)

9130603 (Flat)

Warnings (WARNINGS)

Ophthalmic ointments may retard corneal healing.

Description (DESCRIPTION)

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP is a sterile antimicrobial ointment formulated for ophthalmic use.

Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units/mg. The structural formula for bacitracin A is:

Polymyxin B sulfate is the sulfate salt of polymyxin B 1 and B 2, which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units/mg, calculated on an anhydrous basis. The structural formulae are:

Each gram contains: Actives: Bacitracin Zinc equal to 500 bacitracin units and Polymyxin B Sulfate equal to 10,000 polymyxin B units; Inactives: Mineral Oil and White Petrolatum.

Precautions (PRECAUTIONS)

As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. Appropriate measures should be taken if this occurs.

How Supplied (HOW SUPPLIED)

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP is available in tubes with an ophthalmic tip applicator in the following size:

tube of 3.5g -NDC 68071-5267-3

Adverse Reactions (ADVERSE REACTIONS)

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Contraindications (CONTRAINDICATIONS)

This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Clinical Pharmacology (CLINICAL PHARMACOLOGY)

Polymyxin B sulfate attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and Haemophilus influenzae species.

Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.

Indlcatlons and Usage (INDlCATlONS AND USAGE)

For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.

Principal Display Panel (PRINCIPAL DISPLAY PANEL)

Dosage and Administration (DOSAGE AND ADMINISTRATION)

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection.

FOR OPHTHALMIC USE ONLY


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)